RESOLUTE 2.0 Covid-19 test kit secures approval in Australia for Covid-19. Credit: Prachatai.

Temasek’s wholly-owned subsidiary Advanced MedTech has announced that Australia’s Therapeutic Goods Administration (TGA) granted approval for Singapore-made RESOLUTE 2.0 direct multiplex Reverse-Transcription Polymerase-Chain-Reaction (RT-PCR) test kit for Covid-19.

Co-developed by Singapore’s Agency for Science Technology and Research and DSO National Laboratories (DSO), the kit has been made available for clinical use by Advanced MedTech.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Approval from TGA will enable the test kit to be used in laboratories and medical institutions across the country.

The RESOLUTE 2.0 test kit functions without the need for viral RNA extraction from patient test samples, making it one of the few such RT-PCR tests to get approval from TGA.

Advanced MedTech noted that the kit has high sensitivity and specificity towards SARS-CoV-2 despite a shortened laboratory processing time.

This can reduce potential human errors while reducing exposure of the virus to lab technicians and can deliver test results in half the time than other RT-PCR test kits.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the test kit can be paired with the complementary RAVE automated robotics lab system to process four times more daily throughput compared with the usual RT-PCR test.

RESOLUTE 2.0 will be used at a new Covid-19 testing lab that will open in Changi Airport, Singapore, this year.

Besides nasopharyngeal (NP) Covid-19 testing, RESOLUTE 2.0 test kit has recently received approval from Singapore’s Health Sciences Authority for deep-throat saliva (DTS) and oropharyngeal / middle turbinate (OPMT) testing.

Advanced MedTech Group CEO Abel Ang said: “We are pleased to work with the Australian authorities and Singapore’s Health Sciences Authority on attaining TGA’s approval, to help safely reopen their dynamic economy and bring jobs and trade back into the country.”